CEPI

2 articles

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna launched its first human trial for an experimental mRNA vaccine against the Bundibugyo Ebola strain, backed by a $50 million CEPI partnership. The study enrolls 80 volunteers in Canada amid a

reuters · 2026-08-04 08:03

Moderna Partners with Global Health Coalition to Develop Bundibugyo Ebola Vaccine

Moderna secured up to $50 million from CEPI to develop a vaccine against the Bundibugyo ebolavirus strain amid an ongoing outbreak in the Democratic Republic of Congo. Additional funding from Gavi and

reuters · 2026-06-01 02:37